Fulgent Genetics, Inc. Quarterly Goodwill in USD from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Fulgent Genetics, Inc. quarterly Goodwill history and growth rate from Q2 2021 to Q3 2024.
  • Fulgent Genetics, Inc. Goodwill for the quarter ending September 30, 2024 was $22.1M, a 84.5% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $22.1M -$120M -84.5% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $22.1M -$120M -84.5% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $22.1M -$121M -84.6% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $22.1M -$121M -84.6% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $142M +$21.5M +17.9% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $142M +$20.6M +17% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $143M +$92.1M +181% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $143M +$92.1M +181% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $120M +$71.6M +147% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $121M +$98.2M +425% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $51M Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $50.9M Dec 31, 2021 10-K 2023-02-28
Q3 2021 $48.7M Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $23.1M Jun 30, 2021 10-Q 2021-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.